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Although the composition of the human microbiome is now well-
studied, the microbiota’s >8 million genes and their regulation
remain largely uncharacterized. This knowledge gap is in part be-
cause of the difficulty of acquiring large numbers of samples ame-
nable to functional studies of the microbiota. We conducted what
is, to our knowledge, one of the first human microbiome studies in
a well-phenotyped prospective cohort incorporating taxonomic,
metagenomic, and metatranscriptomic profiling at multiple body
sites using self-collected samples. Stool and saliva were provided
by eight healthy subjects, with the former preserved by three
different methods (freezing, ethanol, and RNAlater) to validate
self-collection. Within-subject microbial species, gene, and tran-
script abundances were highly concordant across sampling meth-
ods, with only a small fraction of transcripts (<5%) displaying
between-method variation. Next, we investigated relationships
between the oral and gut microbial communities, identifying
a subset of abundant oral microbes that routinely survive transit
to the gut, but with minimal transcriptional activity there. Finally,
systematic comparison of the gut metagenome and metatran-
scriptome revealed that a substantial fraction (41%) of microbial
transcripts were not differentially regulated relative to their ge-
nomic abundances. Of the remainder, consistently underexpressed
pathways included sporulation and amino acid biosynthesis,
whereas up-regulated pathways included ribosome biogenesis
and methanogenesis. Across subjects, metatranscriptional profiles
were significantly more individualized than DNA-level functional
profiles, but less variable than microbial composition, indicative of
subject-specific whole-community regulation. The results thus detail
relationships between community genomic potential and gene ex-
pression in the gut, and establish the feasibility of metatranscrip-
tomic investigations in subject-collected and shipped samples.
Of all of the human microbiomes across the diverse landscapeof the human organism, the oral and gut microbiome rep-
resent the two best studied to date. Both microbiomes are sub-
ject to distinctive environments along the gastrointestinal tract
and have their own unique ecologies. Several hundred taxa live
in and along the saliva, teeth, and gingival structures, and over
500 taxa have been estimated to inhabit the distal gut (1).
However, although robust methods for studying diversity of the
human microbiota exist for the oral and gut microbiome, recent
studies suggest that functional activity may vary widely across hosts
and in response to distinct perturbations (2, 3), and highlight the
need for methods development that bridges analyses of meta-
genomic and metatranscriptomic interrogations of the microbiome.
Early high-throughput metatranscriptomic investigations of
microbial communities were focused largely on ocean-derived
environmental samples (4–6). These efforts demonstrated the
feasibility of RNA-based profiling of microbial community structure,
function, and diversity, and also produced large amounts of novel
sequence information (transcripts) unseen by earlier metagenomic
investigations. Metatranscriptomic analysis has subsequently been
applied to the human gut microbiome, revealing strong intersubject
and temporal variability in microbial gene expression, as well as
core modules of actively transcribed versus repressed functions (7–
9). In addition, metatranscriptomic analyses of the gut microbiome
during exposure to dietary (10) and xenobiotic (2) interventions
have revealed significant alterations of the microbial community
gene-expression profile, but often without large changes in overall
community structure. One of the next major challenges facing hu-
man microbiome studies is relating the current understanding of
microbial ecology to this growing knowledge of the biomolecular
activities and regulatory systems of the microbiota (11).
Although recent population studies have established a frame-
work for interrogating the community composition and genomic
potential of these microbiomes, it is not yet well-understood
how genomic potential relates to whole-community transcriptional
regulation. This knowledge gap is in part because of the lack of
standardized human microbiome sampling methodologies appro-
priate both for functional assays of the microbiota and for large
cohort-based research (12, 13). Despite the success of efforts by
the HumanMicrobiome Project (14) andMetaHIT consortia (15),
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identification of best practices and experimental processes that
affect microbiome measurements represents a key challenge for
functional meta’omics and for enabling microbiome investigation
in larger epidemiological studies. In particular, the field requires
development of microbiome sampling methods that are: (i) cost-
effective, (ii) easily applied outside of a clinical setting, (iii) ame-
nable to a variety of downstream meta’omic analyses, (iv) highly
accurate in comparison with clinically collected controls, and (v)
devoid of large biases or batch effects.
In this work, we proposed and validated a method for studying
functional aspects of the microbiota in large human cohorts. We
then applied the data collected during the validation process to
address important knowledge gaps regarding relationships be-
tween the oral metagenome, gut metagenome, and gut meta-
transcriptome. Working with eight subjects from the Health
Professionals Follow-up Study (HPFS) cohort, we demonstrated
the representativeness of self-collected, self-shipped saliva and
stool samples in metagenomic and metatranscriptomic assays of
the microbiome. Comparing saliva and stool samples from the
same subject further allowed us to explore microbial co-occur-
rence relationships between the oral and gut environments. In
particular, only a small number of abundant oral residents sur-
vived transport to the gut environment, and their functional
activity there was consistently greatly reduced. This proved to be
the case even when microbes were identified at the strain level,
indicating the transport of one population per species rather
than the differentiation of two niche-specific subpopulations.
Finally, we compared and contrasted the metagenomic and
metatranscriptomic compositions of the human gut. Although
metagenomic analysis reveals the functional potential of a mi-
crobial community, it remains largely unknown how this potential
is translated to functional activity, as measured by the metatran-
scriptome. Our analysis revealed that although functional poten-
tial and activity were often closely coupled in the gut, they were
also distinguished by two strong forces: (i) a subset of microbial
functional activities that were consistently transcriptionally up- or
down-regulated in the gut, and (ii) activities that varied in a highly
subject-specific manner in the context of a common functional
potential. Together, these results provide a community-wide pro-
file of biomolecular regulatory processes in the gut, as well as
validating one of the first protocols appropriate for large-scale
functional profiling of the microbiome in human populations.
Results
Self-Collected Stool Aliquots Provide Representative Metagenomes
and Metatranscriptomes. We recruited eight members of the HPFS
cohort to provide saliva and stool samples to dissect relationships
between the human oral metagenome, gut metagenome, and gut
metatranscriptome. To simultaneously evaluate the feasibility of
sample self-collection and shipping methods in functional studies of
the human microbiome, saliva and stool samples were self-collected
by the subjects and then stored on ice for delivery to our laboratory
facilities within 24 h following an established protocol (14). We
additionally evaluated this standard transport procedure relative to
freshly collected, immediately processed samples and found only
minimal differences (SI Appendix, SI Methods and Fig. S1). Upon
arrival, aliquots of each stool sample were fixed in ethanol and
RNAlater and then stored at ambient temperature for 48 h to
simulate shipping conditions; additional aliquots were kept frozen
as controls. DNA and RNA were subsequently extracted from the
samples, assessed to ensure high-quality (RNA integrity number,
RIN, scores) (Methods and SI Appendix, Table S1), and sequenced
by Illumina HiSeq (Methods). The resulting raw read data were
processed to remove low-quality reads and human contamination
and finally profiled at the taxonomic and functional levels using
MetaPhlAn (16) and HUMAnN (17), respectively (Fig. 1).
We first sought to determine whether subject-collected, fixed,
and shipped samples provided equivalent metagenomic and
metatranscriptomic data to state-of-the-art fresh-frozen sample-
collection protocols (14). This was assessed quantitatively by de-
termining the extent to which stool samples taken from the same
individual but handled by different methods yielded equivalent
metagenomic and metatranscriptomic profiles. We thus compared
profiles of microbial species, gene, and transcript abundances
from 24 stool samples: one from each of eight subjects subdivided
and stored by three different methods before DNA/RNA extrac-
tion and sequencing (frozen control, ethanol-fixed and mock-
shipped, and RNAlater-fixed and mock-shipped) (Fig. 1). We
found that for all three types of meta’omic profiles (species, genes,
and transcripts), within-subject correlations between frozen and
mock-shipped samples were universally very strong (minimum
Spearman’s r = 0.83, P  0.001), with gene-level abundances
being the most consistent between methods, followed by species,
and then transcripts. Both direct comparisons (Fig. 2 A–C) and
overview ordination (SI Appendix, Fig. S2) supported the con-
clusion that subject-shipment of samples had minimal effect on
meta’omic profiling, particularly in contrast to the typically large
intersubject differences.
Effects of Sample Handling Method on Individual Meta’omic Features.
To assess the contribution of individual features (e.g., specific
microbial species or genes) to this strong global agreement, we
performed two-way ANOVA tests on each metagenomic and
metatranscriptomic feature, normalizing abundance data (Methods)
to partition feature variance across the eight subjects and three
sample handling methods (Fig. 2 D–F). Only features exceeding
a minimum relative abundance of 10−4 (0.01%) in at least 3 of the
24 samples were considered. Relative to between-subject variation,
no individual microbial species demonstrated statistically significant
variation across sample collection methods after correction for
multiple hypothesis testing (Benjamini–Hochberg α = 0.05) (18)
(Fig. 2D). Similarly, sample handling method was not observed to
have a statistically significant effect on the relative abundance of
any individual genes (Fig. 2E). These findings are consistent with
the strong within-subject, between-method agreements observed for
DNA-level species and gene relative-abundance profiles in the
correlation analyses described above (Fig. 2 A and B), and further
suggest that—in addition to strong global agreement—individual
metagenomic measurements are robust to subject-collected stool
sample handling methods.
The effect of sample shipping on metatranscriptomics was
comparably small, with only a very small minority (n = 84, <5%
of total) of transcripts exhibiting statistically significant variation
across sample handling methods (Fig. 2F and Dataset S1). The
nature of these differentially abundant transcripts was consistent
with a pattern of live cells responding to an altered environment
via changes in gene regulation. For example, up-regulated genes in
ethanol-fixed samples were largely involved in oxidative metabolic
processes, a signal consistent with bacteria responding to a combi-
nation of oxygen exposure and a new carbon source. On the other
hand, a subset of genes up-regulated in the RNAlater-fixed samples
were involved in response to osmotic stress [e.g., the glycine beta-
ine/proline transport system (19)], which is consistent with the high
saline content of RNAlater solution. It is also possible that some
transcripts experienced a sample handling method effect because of
variation in RNA stability across the three storage conditions.
Comparison of Oral-Gut Microbial Ecology in the HPFS and Human
Micobiome Project Cohorts. After establishing the data quality of
subject-collected samples, we next sought to meta-analyze the
relationship between the oral and gut microbial communities in
our own HPFS cohort and the larger healthy population of the
Human Microbiome Project (HMP) (20) (Fig. 3A). In addition to
characterizing potential microbial transit along the gastrointestinal
tract, this contextualized our eight subjects within a broader pop-
ulation, as the HPFS participants were healthy but of both restricted
E2330 | www.pnas.org/cgi/doi/10.1073/pnas.1319284111 Franzosa et al.
geography (Boston metropolitan area) and age range (over 65). We
identified a subset of 62 commonly occurring species in the eight
frozen HPFS saliva and stool samples and compared their abun-
dance profiles with 69 oral (tongue dorsum) and 81 stool samples
from the HMP. As expected, differences in body-site specific ecol-
ogy proved to be the largest effect in both cohorts, with HPFS and
HMP stool samples forming a single, well-mixed cluster and HPFS
saliva samples associated with but distinct from HMP oral meta-
genomes from the buccal mucosa and tongue dorsum (SI Appendix,
Fig. S3). Whereas the compositions of the oral versus gut samples
were largely distinct, we did observe a small number of species that
occurred regularly at both body sites (Fig. 3A).
Detection of Oral Bacterial Strains in the Gut Microbiota. Although
the oral and gut environments are anatomically linked, the de-
gree of exchange between their resident microbiota is not com-
pletely understood (21). Bacterial species from the oral community
are carried along with food into the stomach, but the degree to
which they survive or remain biologically active in the lower gas-
trointestinal tract has not been systematically characterized, par-
ticularly whether oral microbes contribute to the stable commensal
gut community as measured by the stool. We first examined our
frozen saliva and stool samples for cases of bacterial species co-
occurring in the oral and gut communities of each subject. We
defined a species as co-occurring if, for at least two subjects, the
species occurred with relative abundance greater than 10−2 (1%)
in a subject’s saliva sample and greater than 10−5 (0.001%) in the
same subject’s frozen stool sample. Of 33 species meeting the first
criterion (common oral species), eight met our criteria for
detection in the stool: four members of the Streptococcus genus
(Streptococcus salivarius, Streptococcus parasanguinis, Strepto-
coccus australis, and Streptococcus sanguinis), along with Hae-
mophilus parainfluenzae, Veillonella atypica, Veillonella parvula,
and Actinomyces odontolyticus (Fig. 3B). For each of these spe-
cies, the typical drop in relative abundance between the oral and
gut communities was one-to-two orders-of-magnitude, with
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Fig. 2. Taxonomic and functional profiles are consistent across sample handling methods. Global profiles of (A) species composition, (B) gene-level functional
composition, and (C) transcript-level functional composition were highly concordant in within-subject comparisons of frozen controls vs. mock-shipped
samples (Spearman’s rank correlation coefficient); black bars represent the averages across each group of eight correlation coefficients. Sample handling
effect was further quantified by two-way ANOVA for all (D) species, (E) genes, and (F) transcripts detected with relative abundance of at least 10−4 (0.01%) in
at least three samples. Following correction for multiple hypothesis testing, <5% of transcripts showed a strong, significant effect from choice of sample
handling method; we observed no significant sample handling effects for either species or genes. Vertical red lines represent the threshold for statistical
significance (Benjamini–Hochberg FDR, α = 0.05); features above the horizontal red lines have greater between-method variation than between-subject
variation.
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higher oral abundance generally corresponding to higher gut
abundance. This finding suggests that, although DNA from these
oral species does survive transit to the gut, it does not form
a dominant component of that community.
If a small fraction of oral microbiome members do survive
transit to the healthy gut, the gut metatranscriptome provides
one means of assessing their active biological contribution to this
community, albeit agnostic of their transcriptional activities at
the oral site. Our metagenomic samples were assessed, among
other methods, by mapping DNA reads to sets of species-specific
marker genes using MetaPhlAn (16) (Methods). We applied the
same procedure to RNA read data, in which case MetaPhlAn
provides a profile of a subset of the metatranscriptome that can
be unambiguously assigned to individual species. Based on this
analysis, we found that when oral species were detectable in the
gut at the DNA level, they rarely appeared to be transcriptionally
active there. It was only in those cases where an oral species
achieved its highest DNA abundance in the gut that its species-
specific RNA was detected, and typically with relative abundance
one-to-two orders-of-magnitude lower than the corresponding
DNA abundance (some cases of RNA nondetection may corre-
spond to exceptionally small, but still nonzero, RNA abundances
that fell below our detection limit). As oral species’ abundances
in the gut community were already multiple orders-of-magnitude
lower than in the oral microbiome, this indicates that oral microbes
that do survive transit to the gut are not stable, active contributors
to its ecology.
Although this evidence is consistent with a pattern of abun-
dant oral species passaging through the gut at low levels, co-
occurrence could also be explained by separate strains of the
same species adapted to the oral and gut environments. To
evaluate whether oral and gut signatures of a species represent the
same or different strains, we compared profiles of species-specific
marker-gene presence and absence across subjects’ stool and sa-
liva samples. These profiles capture gene gain and loss events in
specific strains of a species and were used here as molecular
“barcodes” for identifying or differentiating strains (Methods).
Barcodes for common oral species often differed markedly across
the eight saliva samples, indicating the presence of subject-specific
strain variation (SI Appendix, Figs. S4–S11). However, in cases of
within-subject oral-gut species co-occurrence, we rarely detected
markers for a species in a subject’s stool sample that were not
also seen in the subject’s saliva sample. This finding supports the
hypothesis that oral-gut species co-occurrence is driven not by
separate pools of niche-adapted strains of the same species, but
instead by oral strains surviving transit to the gut in low quantities.
An even smaller number of abundant gut microbes occurred at
appreciable levels in the oral community, the only significant
example being Dialister invisus; this was true for samples from
both the HMP and HPFS cohorts (Fig. 3C). There were three
cases of D. invisus oral-gut co-occurrence among the eight HPFS
subjects, and in each case the same strain was carried with high
abundance in the stool and low abundance in the saliva (SI
Appendix, Fig. S12). Curiously, despite its high DNA abundance
in the gut, D. invisus made almost no contribution to the pool of
species-specific transcripts, an indicator of reduced transcrip-
tional activity (Fig. 3C and SI Appendix, Fig. S13). Of the re-
maining five subjects, four carried D. invisus exclusively in the
oral community. This evidence resolves previously disparate
ecologies for D. invisus, which was isolated from the human oral
cavity (22) but also identifed as a marker for human stool (23),
suggesting that it is atypically capable of persisting at high
abundance in both the oral and gut communities and may freely
transit between the two.
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Fig. 3. Oral-gut ecology in the HPFS and HMP cohorts. (A) We isolated species observed in the eight pairs of frozen stool and saliva samples from the HPFS
cohort with relative abundance of at least 10−2 (1%) in two HPFS samples. The taxonomic profiles of these species were compared with stool and tongue
samples from the HMP cohort, with tongue representing the oral community. Samples were clustered by Bray–Curtis distance, and species were clustered by
rank correlation. Note that samples cluster strongly by body site (oral vs. gut). Highly abundant oral species are more likely to be detected at low levels in the
gut. Green numbers associate oral-gut co-occurring species with detailed abundance profiles in B and C. (B) Eight abundant oral species detected in the HPFS
saliva samples were detectable at low abundance in the stool samples from the same individuals, but showed minimal transcriptional activity in the stool. Gray
lines connect oral DNA (light blue), gut DNA (dark blue), and gut RNA (red) from the same individual. (C) D. invisus is an unusual example of a gut-dominant
species that also occurs in the oral cavity.
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Relating Microbial Genes in the Gut at the DNA and RNA Levels. We
next investigated possible global models for metagenome vs.
metatranscriptome regulation in the gut microbiota. Among
the host-adapted microbes in this community, DNA and RNA
abundances would be correlated if many genes were not differ-
entially regulated and were transcribed at the same constant rate.
This would be the case, for example, if typical gut microbe mo-
lecular activity was regulated by genome modifications over
evolutionary time, as opposed to transcriptional regulation on
a more rapid time scale. To test this theory, we quantified the
relative abundances of genes and transcripts using HUMAnN
(17) in the HPFS stool samples, with the Kyoto Encyclopedia of
Genes and Genomes (KEGG) Orthogroups (KO) database as
a reference set for gene families (Methods). Across all samples,
a total of 3,292 KOs were observed with relative abundance of at
least 10−4 (0.01%) at either the DNA or RNA level. Averaged
over the eight frozen stool samples, we found that gene abun-
dance and corresponding transcript abundance were well cor-
related (Spearman’s r = 0.76; two-tailed P  0.001) (Fig. 4).
To identify differentially regulated transcripts, we computed
the log RNA/DNA abundance ratio for each gene on a subject-
by-subject basis and then tested whether the mean of the eight log
ratios was significantly different from zero following false-discovery
rate (FDR) correction (indicating a pattern of consistent over- or
underexpression) (Dataset S2). Although a substantial fraction
of KOs were not consistently differentially regulated in the gut
(nonsignificant fold-change or fold-change < 2; n = 1,340, 41%),
we also observed many transcripts whose relative abundances
were an order-of-magnitude higher or lower than expected from
the DNA abundance of their corresponding gene families (sig-
nificant fold-change > 10; n = 724, 22%) (Fig. 4). For example,
tetA, which encodes a transporter protein conferring tetracycline
resistance, was on average 1,000-times more abundant at the
RNA level than the DNA level, one of the strongest such effects
(one-sample t test, two-tailed P < 10−5) (Fig. 4A). We then used
these rankings of gene-level expression as input to a functional
enrichment analysis, searching for KEGG pathways and modules
whose member genes (KOs) were enriched for consistent over-
or underexpression (Fig. 4 and Dataset S3). All of the over- and
underexpression relationships discussed in the following sections
were both of large effect (fold-change > 2) and statistically sig-
nificant following FDR correction (Methods).
Microbial genes encoding ribosomal proteins were among the
most strongly overexpressed (Fig. 4B). Note that these are, of
course, distinct from the ribosomal rRNAs depleted from met-
atranscriptomic assays (Methods). Indeed, we observed distinct
clusters of ribosomal protein-coding gene overexpression across
three domains of life, with bacterial ribosomal genes having
the highest overall abundance, followed by archaeal ribosomal
genes, and finally eukaryotic ribosomal genes detectable at the
low end of DNA relative abundance. Notably, these archaeal ribo-
somal genes occurred as part of a “burst” of other highly expressed
archaea-associated functions, including methanogenesis (Fig. 4C)
and the archaeal RNA polymerase. This signal can be explained
predominantly by the presence of the archaeon Methanobrevibacter
smithii in five of the eight HPFS subjects. In these five subjects, the
relative abundance ofM. smithii at the DNA level ranged from 0.005
to 0.053 (0.5–5.3%), whereas its relative contribution to the pool of
species-specific transcripts ranged from 0.021 to 0.147 (2.1–14.7%)
(SI Appendix, Fig. S13). This finding confirms that M. smithii tends
to be highly transcriptionally active relative to other species in the
gut (9), an activity associated with its unique functional role in
maintaining gut energy balance (24) by removal of hydrogen and
correspondingly increased rates of fermentation among its bacterial
neighbors (25). The second carbon oxidation step of the citrate cycle
was also found to be highly overexpressed (Fig. 4D). Given that the
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vast majority of gut-dwelling bacteria are anaerobic (26), the ob-
served overexpression of the citrate cycle is best explained by its role
in replenishing biochemical intermediates, rather than its role in
aerobic metabolism. This finding is consistent with the observation
that only genes involved in one part of the cycle (reactions yielding
oxaloacetate) were significantly overexpressed and emphasizes the
need to avoid the blind application of broad pathway names to
specific biochemical functions observed in the microbiome.
Conversely, other metabolic routes were consistently under-
expressed, including the metabolism of starch and sucrose
(Fig. 4E). Moreover, many pathways involved in the biosynthesis
of small metabolites tended to be expressed at relatively low
levels (Fig. 4F), consistent with earlier findings (8). Because
these compounds will have high bioavailability in the gut because
of the host’s diet, it is logical that it would, in most cases, be more
energetically favorable to import them rather than synthesizing
them directly. Genes involved in sporulation were also strongly
underexpressed (Fig. 4G). Sporulation is a stress-response mecha-
nism used by Gram-positive bacteria to survive in nonideal con-
ditions (e.g., nutrient depletion) and also plays a role in certain
bacterial infections [e.g., Clostridium difficile (27)]. However, nei-
ther of these conditions is applicable to this cohort’s healthy human
gut environments, with a presumably undisturbed baseline spore
fraction, and hence it is not surprising that the sporulation pathway
is underexpressed. Finally, we also observed peptidoglycan bio-
synthesis to be significantly underexpressed in the gut microbiome
(Fig. 4H). Peptidoglycans are critical components of bacterial cells
walls and have roles in the maintenance of cell shape and integrity
(28). To perform those roles, peptidoglycan biosynthesis must
be carefully regulated to coordinate with cellular growth (29).
Consistent with this idea, we found that peptigoglycan bio-
synthesis transcription and ribosomal protein transcription
were strongly correlated across species (Spearman’s r = 0.78; two-
tailed P  0.001) (SI Appendix, SI Methods and Fig. S14). How-
ever, within species, ribosomal protein-coding genes tended to be
overexpressed relative to their metagenomic abundance, whereas
peptidoglycan biosynthesis tended to be underexpressed (consis-
tent with the community-level trends seen in Fig. 4). This pattern
may result from the fact that the end-products of ribosomal pro-
tein transcription are physical building blocks of the ribosome and
need to be continuously synthesized, whereas the end-products
of peptidoglycan biosynthesis transcription are enzymes that act
on the building blocks of the cell wall (and may thus persist at
smaller concentrations).
The Metatranscriptome Varies Significantly Among Subjects Despite
Metagenomic Concordance. Recent large-scale studies of the hu-
man microbiome have shown that, although taxonomic compo-
sition at a particular body site can differ dramatically from one
individual to the next, functional composition tends to be much
more conserved (20, 30). Indeed, we observed similar patterns in
our metagenomic (DNA) data from the HPFS cohort. Although
there was considerable variation in the 10 most abundant genera
across the eight subjects (Fig. 5A), the 10 most abundant func-
tional categories were very well conserved (Fig. 5B). However,
when we examined the 10 most abundant functional categories
as measured from metatranscriptomic (RNA) data, we found
that they were noticeably more variable than their DNA-based
counterparts, although still more conserved than genus-level
taxonomic composition (Fig. 5C).
To more rigorously quantify these observations, we computed
within-subject evenness and between-subject dissimilarity for the
taxonomic, DNA-level function, and RNA-level function com-
position for the eight frozen stool samples. Taxonomic compo-
sition was significantly less even than either DNA- or RNA-level
functional composition, with a small number of (not always the
same) genera dominating each individual’s gut microbiome
(Wilcoxon signed-rank test, two-tailed P = 0.01) (Fig. 5D).
Moreover, in line with our qualitative observation above, we
found that between-subject variation in RNA-level functional
composition was significantly stronger than between-subject
variation in DNA-level functional composition (P < 10−5) (Fig.
5E). Thus, although subjects share a highly conserved gut met-
agenome derived from microbial contributors that are quite
variable among subjects, its constituent functions are fine-tuned
at the transcriptional level in a subject-specific manner.
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Specific Pathways That Are Highly Variable at the Transcriptional
Level. The previous section highlighted that microbial function
in the gut is considerably more variable at the metatranscriptomic
(RNA) level than the metagenomic (DNA) level. To better
understand the specific functions driving this variability, we
computed the coefficient of variation for each gene family (KO)
across the eight subjects at the DNA and RNA levels. We then
ranked gene families by the ratio of their RNA coefficient of
variation to DNA coefficient of variation (Dataset S4). This
procedure highlights between-subject variation in transcript ex-
pression while factoring out the influence of (i) absolute ex-
pression level and (ii) variation in underlying gene copy number
(DNA abundance). We used the list of transcripts ranked by
expression variability to identify KEGG pathways and modules
(31) that were enriched for differential regulation across subjects
(Fig. 6 and SI Appendix, Fig. S15 and Dataset S5).
Genes encoding protein components of the bacterial ribosome
were among the most variable at the RNA level (Fig. 6A). As
shown above, these genes were also among the most highly and
consistently overexpressed in our dataset (Fig. 4A). The magni-
tudes of these genes’ normalized RNA-level expression vari-
ability were driven in large part by their highly conserved
abundances at the DNA-level. We expect this to be the case for
genes that are extremely well conserved across species, as is the
case for ribosomal genes. This represents the simplest route by
which metagenomic stability can be achieved in that if every
bacterial cell contributes a copy of a gene, the gene’s relative
abundance depends only on the average number of genes per
bacterial cell, which may be relatively conserved across subjects.
Chaperone-coding genes also tended to be highly variably
expressed across subjects, which could, for example, be because
of variation in cellular stress conditions across samples (Fig. 6B).
Like ribosomal proteins, chaperones are highly conserved across
bacterial species [the four examples in Fig. 6C are encoded in the
genomes of >99% of commonly occurring gut species (31)].
Notably, the chaperone signal is relatively consistent across the
three sample handling methods (SI Appendix, Fig. S15).
Metagenomic stability can also occur in the absence of strong
gene or pathway conservation across bacterial species. For ex-
ample, enzymes involved in uronic acid metabolism are found
in only 10–30% of commonly occurring gut species, but their
overall metagenomic abundance was relatively stable across
subjects (Fig. 6C). This finding suggests that there exists a niche
in the human gut for metabolizing uronic acids (a class of sugars
derived from proteoglycans) that is differentially filled by distinct
subsets of each individual’s microbiome. Like ribosomal protein-
and chaperone-coding genes, genes involved in uronic acid me-
tabolism were also found to be variably transcribed across subjects,
perhaps because of variation in the subject’s dietary patterns. As a
final example, proteasome-associated genes are less broadly con-
served across bacteria, but are common among archaea (Fig. 6D)
(32). Although the abundance of proteasome-associated tran-
scripts was highly variable at the RNA level, this variation was
largely attributable to differences in the DNA-level abundance of
their associated genes across subjects (i.e., unlike the previous
examples, this functional module was not conserved at the meta-
genomic level). This finding further underscores the usefulness of
combined metagenomic and metatranscriptomic sequencing: only
by considering these two types of data simultaneously can we ac-
curately distinguish variability in community-level transcriptional
control from underlying variation in community structure.
Discussion
These results have validated a novel self-collected, self-shipped
gut microbiome sample collection method as providing repre-
sentative metagenomic and metatranscriptomic profiles from
large human cohorts, such as the HPFS. This method extends
previous scalable sample collection methods focused on amplicon
profiling to allow shotgun DNA and, critically, RNA sequencing.
Providing a means by which subjects can collect samples at home
and mail them to analysis centers greatly improves the privacy,
convenience, and feasibility of the collection process relative to
laboratory-based or frozen collection. We expect this method to
have a marked effect on rates of volunteerism in microbiome
studies, increasing both the size of study populations and their
ability to provide serial samples longitudinally over time. Allowing
samples to be shipped at ambient temperature further enhances the
geographical range that can be effectively incorporated. Although
our results are focused on the oral and gut microbiota (via saliva
and stool samples), the validation framework we present here is
extensible and highly applicable to other microbial communities
and their associated sampling efforts (e.g., human body sites outside
of the gastrointestinal tract and environmental samples).
In addition to validating methods for microbiome sample
collection, to our knowledge this work represents one of the first
efforts to probe the functional activity of the human gut micro-
biome via combined metagenomic and metatranscriptomic se-
quencing. This approach produced the striking finding that more
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than half of the variation in microbial community gene expres-
sion can be explained by metagenomic composition (Spearman’s
r = 0.76; r2 = 0.58 = 58%). In other words, a gene family’s copy
number in the community appears to be the (slightly) dominant
determinant of the abundance of its corresponding transcript.
Microbial gene expression is no doubt influenced by many other
factors, such as variation in the gene’s promoter strength across
genomes (strains) and the regulatory states of cells within and
across species. However, our results indicate that these factors
are on par with genome content in dictating the metatran-
scriptome composition of the healthy human gut. Notably, our
observation of strong correlation between metagenomic and meta-
transcriptomic composition is consistent with the majority of genes
across the majority of microbial genomes being transcribed at sim-
ilar, relatively fixed rates, a reasonable null model for a community
of single-celled organisms well-adapted to their environment. Sig-
nificant deviations from this model are indicative of finer-level
transcriptional control occurring within the microbiome, and can be
divided into two types, both of which were observed in this study: (i)
consistent up- or down-regulation of a function across individuals,
and (ii) regulation that varies in a subject-specific manner.
We observed many examples of gene families that were met-
agenomically abundant but consistently down-regulated at the
transcriptional level. The relative functional importance of such
genes to the healthy human gut will tend to be overestimated
by metagenomics-only approaches. However, the fact that such
functions persist in the gut microbial community’s reservoir of
functional potential suggests that they are selectively advanta-
geous under conditions not captured by this study. For example,
although sporulation was inactivated in these healthy subjects
with, presumably, a fully populated spore component, this
pathway persists as a survival mechanism to be activated in re-
sponse to stress, starvation, or perturbation of the existing spore
population (as might occur subsequent to antibiotic treatment).
Conversely, a small number of functional modules were consis-
tently transcriptionally activated well beyond their metagenomic
abundance, and will tend to be underestimated by metagenomics-
only approaches. This was particularly the case for methano-
genesis, which demonstrated transcriptional abundance one-to-two
orders-of-magnitude greater than its metagenomic abundance.
This pathway is particularly important in that it both over-
expresses a highly targeted metabolic capacity and emphasizes
the significant role of a particular phylogenetic group, the
methanogenic archaea, in the gut community of some subjects
(24), including their proposed role in directing the metabolic
programs of other microbial species, and thus altering host
phenotype (33). Combined DNA and RNA sequencing of the
gut microbiota thus provides at least two new insights in-
accessible by DNA sequencing alone: identifying organisms or
pathways differentially regulated on a rapid time scale in re-
sponse to dynamic aspects of the gut environment, and identi-
fying those whose DNA-level contribution alone (high or low) is
not a complete reflection of their role in the community.
Metatranscriptomic data further provide a new lens through
which to investigate human hosts, in addition to insights about
microbial biomolecular activity. In addition to interspecies and
cell–cell transcriptional variation, some transcriptional variation
was attributable to systematic under- or overexpression of func-
tions among individuals. This subject-specific transcriptional fine-
tuning is particularly intriguing in light of the pattern of strong
conservation (lack of variation) we observed in functional potential
(metagenomes) between individuals. The inclusion in this category
of functions, such as ribosomal synthesis and chaperone activity,
are indicative of communities responding to subject-specific envi-
ronments via changes in growth rate and stress response, respec-
tively. Moreover, subject-specific variation in specific metabolite
processing pathways (e.g., up- or down-regulation of uronic acid
utilization) may indicate responses to subjects’ dietary patterns.
Critically, these observations suggest that transcriptional control in
mixed-species microbial communities may operate comparably to
that of our own genome. We all possess much the same genome,
although the proportionally small differences are critical; similarly,
microbial metagenomes are significantly similar among subjects,
with small but important differences (20, 34). However, just as dis-
tinct tissues in the human body take on radically different pheno-
types by altering the expression of this common set of genes, distinct
microbial niches may fine-tune behavior by altering expression of
similar underlying metagenomes.
Subject-specific metatranscriptomic variation, like single
organism transcriptional regulation, can be divided into three
components: (i) variation that is constant over time, (ii) short-
term variation responding to fluctuations in the environment,
and (iii) intercellular stochasticity. Our observation that over- or
underexpression of related functional components is often con-
sistent within individuals but variable between them suggests that
the variation we observe cannot be explained by stochastic fluctu-
ations alone (SI Appendix, Fig. S15). However, from a single cross-
sectional measurement this study cannot determine whether varia-
tion across individuals represents a pattern of microbes adapting to
their host over the long term, or short-term fluctuations around an
otherwise conserved state (for example, response to the subject’s
most recent meal). It is also possible that the variation we observe
represents a combination of these two effects. Taking advantage of
these new methods to track microbial transcription in individuals
over time, or before and after application of a dietary stimulus, will
provide an important future means for disentangling the con-
tributions of short- versus long-term regulatory changes in the gut
and other human-associated microbial ecosystems.
Methods
In summary, eight male subjects provided self-collected stool and saliva
samples for shotgun metagenomic and metatranscriptomic sequencing. To
evaluate the effects of sample handling method on meta’omic assays, each
stool sample was subdivided to produce three aliquots: a fresh frozen con-
trol sample, a sample fixed in ethanol, and a sample fixed in RNAlater. In
addition, the ethanol- and RNAlater-fixed samples were left exposed to the
ambient environment for 48 h to simulate the effects of carrier transport
(“mock-shipping”). DNA was extracted from all samples, and RNA was ad-
ditionally extracted from all stool samples and converted to cDNA. All
samples were then sequenced by Illumina HiSeq and the resulting reads
filtered to identify high-quality microbial DNA and RNA sequences. This
sequence information was used to profile the taxonomic and functional
composition of each sample, allowing us to quantitatively compare within
and between subjects: (i) stool samples subjected to different sample han-
dling methods (by correlation and two-way ANOVA); (ii) saliva and stool
microbial community structure (by hierarchical clustering, ordination, and
strain-level profiling); and (iii) stool DNA- and RNA-level functional sig-
natures (by differential expression and functional enrichment analysis).
Details of these analyses are described in the following sections.
HPFS Cohort and Subject Recruitment. We recruited the eight individuals
sampled in this study from the Health Professionals Follow-up Study, a pro-
spective cohort of 51,529 United States male dentists (58%), veterinarians
(20%), pharmacists (8%), optometrists (7%), osteopathic physicians (4%), and
podiatrists (3%), aged 40–75 y at enrollment, who returned a mailed health
questionnaire in 1986 (www.hsph.harvard.edu/hpfs). Every 2 y, participants
have completed comprehensive questionnaires with updated information
on their lifestyle and medical history, with a follow-up rate exceeding 90%.
In the spring of 2010, 210 active HPFS participants with current addresses in
the greater Boston area were mailed a short questionnaire to assess their
interest in providing stool and saliva samples for a pilot investigation of diet
and gastrointestinal microbiota. We received positive responses from 75%
of participants. From among these participants, we selected 63 men who
represented extremes of Western versus prudent dietary intake and sent
them kits for self-collection of saliva and stool at home. Subject recruitment
and protocols were approved by the Harvard School of Public Health In-
stitutional Review Board.
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Sample Collection. Saliva samples were collected using the self-collection kit
Oragene-DNA OG-500 (DNA Genotek) and accompanying instructions. For
the stool collection, we took advantage of an established protocol well-
received in the HMP cohort, providing us with starting sample material
comparable to previous studies (14). Stool was self-collected by deposition in
a commode specimen collection system (catalog 02–544-208, Fisher Scien-
tific). Both the saliva and stool samples were placed by the subject in a sty-
rofoam box with frozen icepacks for pick-up by a member of our study team
and delivery to our laboratory within 24 h of sample collection. We in-
dependently evaluated the effects of this initial transport protocol on stool
metagenomes and metatranscriptomes by sequencing DNA and RNA from
aliquots of a fresh stool sample that had been (i) immediately flash-frozen
versus (ii) incubated on ice for 24 h (SI Appendix, SI Methods and Fig. S1).
Participants also completed a brief questionnaire to report their recent diet
and other pertinent exposures that may affect specimen composition, in-
cluding recent consumption of antibiotics or probiotics or the use of oral
hygiene products. The sample collection period ran from February to July
2011, during which time we collected samples from 25 participants. From
among these participants, we randomly selected complete samples from
eight men for this analysis.
Laboratory Procedures. Upon receipt at the laboratory, saliva tubes were
frozen to −80 °C. The stool samples were homogenized using a spatula and
separated into three aliquots (fresh-frozen control, mock-shipped RNAlater-
fixed, and mock-shipped ethanol-fixed). The homogenization step was
intended to reduce between-aliquot variability for the purposes of our
methods evaluation; subjects using the self-collection and self-shipping
protocol validated here would not be required to homogenize their stool.
The first 100-mg subsample (control) was flash-frozen on dry ice and then
stored at −80 °C until being thawed for extraction. The control aliquot
represented the baseline composition of the sample upon arrival at the
laboratory, following the initial HMP-based sample collection and transport
protocol described above. To a second 100-mg subsample we added 700 μL
of RNAlater (Ambion) and then allowed the mixture to fix at −4 °C over-
night. A third 1-g subsample was collected using a feces tube with spatula
(catalog 80.623.022, Sarstedt), to which we added 5 mL of 95% (wt/wt) eth-
anol and allowed the mixture to fix at room temperature overnight. The stool
masses described above were acquired by taking a single scoop with a corre-
sponding collection spatula, just as subjects would do when following the
proposed self-collection protocol. Ethanol- and RNAlater-fixed subsamples
were then stored at −80 °C until all samples were ready for the mock-shipping
stage of the experiment. During mock-shipping, all ethanol- and RNA-later
fixed samples were transferred to a cardboard box and subjected to natural
environmental condition changes (at ambient temperatures) for 48 h to mimic
conditions during carrier or mail transport. After this phase, mock-shipped
samples were then stored at −80 °C until extraction; the frozen control and
RNAlater-fixed subsamples entered the extraction pipeline directly, whereas
the ethanol-fixed subsamples were first sliced to yield 100 mg of stool.
DNA and RNA Extraction and Sequencing. For saliva samples, DNA was
extracted using procedures established for the Human Microbiome Project
(14). Stool samples in RNAlater and ethanol were centrifuged at maximum
speed for 10 min and the supernatant removed. DNA and RNA were ex-
tracted and processed following the protocol established in ref. 35. Briefly,
bacterial lysis buffer containing lysozyme and proteinase K was added to
∼100 mg of stool sample, incubated for 10 min, followed by 3 min of bead
beating to extract the nucleic acids. Qiagen AllPrep DNA spin columns were
used for RNA and DNA isolation following the manufacturer’s protocol
(Qiagen). Illumina DNA-seq libraries were generated as previously described
(36) with the following modifications. For each sample, 100 ng of genomic
DNA was sheared to 150–300 bp in size using a Covaris LE220 instrument
(Covaris) with the following parameters: temperature: 7–9 °C; duty cycle:
20%; intensity: 5; cycles per burst: 200; time: 90 s; shearing tubes: Crimp-Cap
microTUBES with AFA fibers (Covaris). DNA fragments were end-repaired, 3′-
adenylated, ligated with indexed Illumina sequencing adapter, and PCR-
enriched, as previously described (37). The resulting Illumina fragment se-
quencing libraries were size-selected to contain inserts of 180 bp ± 3% in
length using a Pippen Prep system (Sage Science) following the manu-
facturer’s recommendations.
For RNA-seq libraries, 5 μg of initial RNA was depleted for ribosomal RNA
using Ribo-Zero (Epicentre), subjected to DNase treatment to deplete
remaining sample DNA, fragmented, and then used as a template for
strand-specific cDNA synthesis by dUTP marking and degradation of second
strand cDNA (35). This procedure has been known to introduce 1–2%
Escherichia coli genomic DNA into the final cDNA library (a result of E. coli-
derived DNA polymerase I and ligase being used in the cDNA generation
steps). Including versus excluding E. coli sequences in downstream bio-
informatic analyses did not affect the conclusions of this work. RIN scores for
all metatranscriptomic samples are provided in SI Appendix, Table S1. The
average RIN score over all samples was 6.9, whereas the averages for the
control, EtOH-fixed, RNAlater-fixed batches were 5.7, 7.0, and 7.8, respectively.
All DNA-based samples were then sequenced by Illumina HiSeq, with each
DNA sample run on a single sequencing lane, and each RNA (cDNA) sample
run on a pair of sequencing lanes. Raw sequences were then filtered to
remove human sequence contamination, quality trimmed, and depleted of
duplicate reads also using HMP protocols (14). Sequences from paired RNA
sample lanes were merged before downstream analyses. Fig. 1 reports av-
erage sequence statistics for all raw and postprocessed samples. Sequence
data are available for download from the Sequence Read Archive with ac-
cession no. PRJNA188481.
Taxonomic and Functional Profiling. We performed taxonomic profiling with
MetaPhlAn (16). Briefly, MetaPhlAn operates by mapping raw sequence
reads to a database of predefined clade-specific marker genes. Markers are
those genes occurring in isolates from a particular clade but not outside of
that clade. After mapping reads to clade-specific marker genes, the resulting
raw counts are normalized for total marker-gene length and outliers,
yielding profiles of (i) clade relative abundance, (ii) marker-gene presence/
absence, and (iii) marker gene abundance (in RPKM units). Because of gene
gain and loss events, an individual strain will not necessarily carry all of the
markers associated with its corresponding species. A specific pattern of
marker presence and absence can therefore be used as a molecular “bar-
code” to identify a strain across samples. Examples of MetaPhlAn-based
strain barcodes are illustrated in SI Appendix, Figs. S4–S12. We defined
“commonly occurring species” to be those detected with relative abundance
of at least 10−2 (1%) in at least two of our eight subjects.
When applying MetaPhlAn to RNA read data, the output is a profile of
relative marker gene transcription across clades (focusing on species-level
measurements in this work). A species’ value in this profile depends on two
factors: (i) its overall genomic abundance in the sample, and (ii) the average
transcriptional level of its unique marker genes. Notably, only the first cri-
terion matters when quantifying species abundance at the DNA level, as
each marker gene is expected to occur at equal frequency after normaliza-
tion. If a species has higher RNA-based abundance than DNA-based abun-
dance, this suggests that its marker genes are more actively transcribed than
marker genes from other species, which we can interpret as an approximate
measure of the species’ clade-specific transcriptional activity. Notably, this
measure can only approximate a species’ overall transcriptional activity, as the
species’ unique marker genes may be more or less actively transcribed than
other pathways (which includes many nonunique genes; e.g., ribosomal RNAs).
We performed functional profiling of genes and transcripts using
HUMAnN (17) based on the KEGG database of gene families and pathways
(31). This procedure involved first mapping quality- and human-filtered DNA
and RNA reads from a meta’omic sample to protein-coding sequences from
the KEGG Orthology using USEARCH (38). We then used HUMAnN to col-
lapse the output of this mapping step to produce a table of relative abun-
dances for all KOs. When the input to USEARCH and HUMAnN are DNA read
data, the resulting functional profile describes the relative abundance of
gene families in the sample; when RNA read data are used as the input, the
profile instead quantifies the corresponding transcripts of these gene fam-
ilies. If a gene family or its corresponding transcript is never observed with
relative abundance above 10−4 (0.01%) across all samples, then it is merged
into an “other” category and excluded from subsequent statistical analysis.
Samples were additionally profiled by mapping reads against a collection of
reference genomes (SI Appendix, SI Methods). Rawmapping results for the eight
control stool metagenomes and metatranscriptomes are provided as Dataset S6.
Statistical Analysis Details. Relative abundance values were arcsine square
root-transformed before performing ANOVA calculations to variance-stabi-
lize data and better approximate normality. Before computing the RNA/DNA
abundance log ratios and RNA- and DNA-level coefficients of variation, all
KO-based relative abundance measurements for a sample were smoothed by
the Witten–Bell method (39). This procedure calculates the probability mass
likely to have been nonobserved because of low frequency events and
evenly distributes it over all nonobserved genes in each sample. This method
can in many cases provide an accurate way to avoid numerical irregularities,
such as dividing a small RNA abundance by zero DNA abundance. The size of
the additional probability mass is equal to the number of “first observa-
tions” over all detected KOs divided by the total number of observations,
which is approximated as the reciprocal of the smallest nonzero relative
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abundance. This procedure was only applied to genes detected with a rela-
tive abundance of at least 10−4 (0.01%) in at least one sample.
We tested sets of log ratios for significant deviation from zero using one-
sample t tests. We subjected nominal two-tailed P values to FDR correction
following the Benjamini–Hochberg method with α = 0.05 (18) (Dataset S2).
Lists of genes ranked by mean RNA/DNA relative abundance ratio across the
eight subjects were further tested for KEGG pathway and module enrich-
ment. Treating pathways and modules as unstructured genesets, we evalu-
ated whether each set was enriched at the top or bottom of the ranked
gene list using a Mann–Whitney U test, comparing the ratios of genes in the
set to those outside the set (Dataset S3). The same procedure was later
applied to genes ranked by mean RNA-level coefficient of variation nor-
malized by DNA-level coefficient of variation (Datasets S4 and S5). Nominal
two-tailed P values for geneset enrichments were FDR-corrected following
the same procedure applied to individual genes.
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